Lyra Therapeutics is abandoning…
Lyra Therapeutics is abandoning work on its rhinosinusitis treatment and [...]
Gary Gibbons, M.D., is retiring as…
Gary Gibbons, M.D., is retiring as National Heart, Lung and [...]
A phase 3 rheumatoid arthritis…
A phase 3 rheumatoid arthritis trial of Lynk Pharmaceuticals’ JAK1 [...]
Teva has penned a second pact with…
Teva has penned a second pact with Royalty Pharma, this [...]
Eikon Therapeutics is planning to…
Eikon Therapeutics is planning to become the second biotech to [...]
The new year has ushered in a flow…
The new year has ushered in a flow of biotech-specific [...]
AirNexis Therapeutics is taking…
AirNexis Therapeutics is taking flight with $200 million and a [...]
Madrigal paid Pfizer $50 million…
Madrigal paid Pfizer $50 million for the rights to a [...]
Menlo Ventures has made a $16…
Menlo Ventures has made a $16 million bet that the [...]
Roche has got in on the B7-H3…
Roche has got in on the B7-H3 action, agreeing to [...]